TITLE

The use and reporting of patient-reported outcomes in phase III breast cancer trials

AUTHOR(S)
Brim, Remy L; Pearson, Steven D
PUB. DATE
April 2013
SOURCE
Clinical Trials;Apr2013, Vol. 10 Issue 2, p243
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
86418589

 

Related Articles

  • A Survey of Ethical and Professional Challenges Experienced by Spanish Health-Care Professionals that Provide Genetic Counseling Services. Abad-Perotín, Reyes; Asúnsolo-Del Barco, Ángel; Silva-Mato, Agustín // Journal of Genetic Counseling;Feb2012, Vol. 21 Issue 1, p85 

    Genetic testing is increasingly applied for diagnosis and clinical treatment. In some countries, genetic counseling services are provided by professionals with specific training in this discipline, whereas other countries have no teaching programs and counseling is offered by physicians, nurses,...

  • Could Good Care Mean Withholding Information from Patients? Long, Benjamin D.; Shuman, Andrew G. // AMA Journal of Ethics;Jan2016, Vol. 18 Issue 1, p6 

    The authors comment on the ethical aspects of physicians' withholding information from patients regarding clinical trial options and discuss its association with responsive patient-centered care by citing the case of a patient named Janet who suffers from breast cancer.

  • Severe Menopausal Symptoms Are Widespread among Survivors of Breast Cancer Treatment Regardless of Time Since Diagnosis. Mortimer, Joanne; Behrendt, Carolyn E. // Journal of Palliative Medicine;Sep2013, Vol. 16 Issue 9, p1130 

    Background: The intensity and persistence of treatment-related symptoms among breast cancer survivors is incompletely understood. Objective: The objective of the study was to estimate prevalence of severe symptoms well after initial treatment for breast cancer, to test whether symptom intensity...

  • Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis. Zullo, Angelo; Ierardi, Enzo; Hassan, Cesare; De Francesco, Vincenzo // Saudi Journal of Gastroenterology;Jan2012, Vol. 18 Issue 1, p11 

    Background/Aim: Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns...

  • A meta-analysis of the relationship between social constraints and distress in cancer patients. Adams, Rebecca; Winger, Joseph; Mosher, Catherine // Journal of Behavioral Medicine;Apr2015, Vol. 38 Issue 2, p294 

    Social constraints on cancer-related disclosure have been associated with increased distress among cancer patients. The goals of this meta-analysis were: (1) to quantify the average strength of the relationships between social constraints and general and cancer-specific distress in cancer...

  • HERStory: The Next Chapter in HER-2-Directed Therapy for Advanced Breast Cancer. VERMA, SUNIL; JOY, ANIL A.; RAYSON, DANIEL; MCLEOD, DEANNA; BREZDEN-MASLEY, CHRISTINE; BOILEAU, JEAN-FRANCOIS; GELMON, KAREN A . // Oncologist;Nov2013, Vol. 18 Issue 11, p1153 

    Untreated human epidermal growth factor receptor-2 (HER-2)-positive advanced breast cancer (ABC) is an aggressive disease, associated with a poor prognosis and short overall survival. HER-2-directed therapy prolongs both time to disease progression and overall survival when combined with...

  • Arts Therapies for Anxiety, Depression, and Quality of Life in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Boehm, Katja; Cramer, Holger; Staroszynski, Thomas; Ostermann, Thomas // Evidence-based Complementary & Alternative Medicine (eCAM);2014, Vol. 2014, p1 

    Background. Breast cancer is one of the most common types of cancer. However, only a few trials assess the effects of arts therapies. Material and Methods. We searched the Cochrane Central Register of Controlled Trials, PubMed, and Google Scholar from their start date to January 2012. We...

  • Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience. EL-OSTA, HAZEM; HONG, DAVID; WHELER, JENNIFER; SIQING FU; AUNG NAING; FALCHOOK, GERALD; HICKS, MARSHALL; SIJIN WEN; TSIMBERIDOU, APOSTOLIA M.; KURZROCK, RAZELLE // Oncologist;Sep2011, Vol. 16 Issue 9, p1292 

    Background. Research biopsies are crucial for exploring the impact of novel agents on putative targets. The current study assesses the safety and success rate associated with performing such biopsies. Methods. We reviewed the medical records of 155 consecutive patients who had one or more...

  • Assessment of an autoinjection device commonly used by patients with multiple sclerosis. D'Arcy, Caroline; Parkes, Laura; Shepherd, Gillian // British Journal of Neuroscience Nursing;Feb2012, Vol. 8 Issue 1, p25 

    Aim: To determine the level of correct use of an autoinjection device for administering interferon beta-1a subcutaneously among patients with relapsing-remitting multiple sclerosis (MS), and to identify training needs to improve technique. Methods: In this Phase IV observational study at 11 UK...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics